Skip to main content

CAMBIOS VASCULARES DURANTE EL ENVEJECIMIENTO Y EN MODELOS ANIMALES DE DEMENCIA DE ORIGEN VASCULAR.

DPI2015-64358-C2-2-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Longitudinal, transcranial measurement of functional activation in the rat brain by diffuse correlation spectroscopy

  • Blanco, Igor
  • Zirak, Peyman
  • Dragojević, Tanja
  • Castellví, Clara
  • Durduran, Turgut
  • Justicia, Carles
Neural activity is an important biomarker for the presence of neurodegenerative diseases, cerebrovascular alterations, and brain trauma; furthermore, it is a surrogate marker for treatment effects. These pathologies may occur and evolve in a long time-period, thus, noninvasive, transcutaneous techniques are necessary to allow a longitudinal follow-up. In the present work, we have customized noninvasive, transcutaneous, diffuse correlation spectroscopy (DCS) to localize changes in cerebral blood flow (CBF) induced by neural activity. We were able to detect changes in CBF in the somatosensory cortex by using a model of electrical forepaw stimulation in rats. The suitability of DCS measurements for longitudinal monitoring was demonstrated by performing multiple sessions with the same animals at different ages (from 6 to 18 months). In addition, functional DCS has been cross-validated by comparison with functional magnetic resonance imaging (fMRI) in the same animals in a subset of the time-points. The overall results obtained with transcutaneous DCS demonstrates that it can be utilized in longitudinal studies safely and reproducibly to locate changes in CBF induced by neural activity in the small animal brain., The project was funded by Fundació CELLEX Barcelona, Ministerio de Economía y Competitividad (PHOTODEMENTIA, DPI2015-64358-C2-1-R and DPI2015-64358-C2-2-R, PHOTOSTROKE), the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2015-0522), the Obra social “la Caixa” Foundation (LlumMedBcn), Instituto de Salud Carlos III / FEDER (Medphotage, DTS16/00087), AGAURGeneralitat (2014-SGR725, 2014SGR-1555), LaserLab-Europe IV. We are indebted to the Experimental MRI 7T Unit of the IDIBAPS for the technical help., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Uric acid Is protective after cerebral ischemia/reperfusion in hyperglycemic mice

  • Justicia, Carles
  • Salas-Perdomo, Angélica
  • Pérez-de-Puig, Isabel
  • Deddens, Lisette H.
  • Tilborg, & Geralda A.F. van
  • Castellví, Clara
  • Dijkhuizen, Rick M.
  • Chamorro, Ángel
  • Planas, Anna M.
Hyperglycemia at stroke onset is associated with poor long-term clinical outcome in numerous studies. Hyperglycemia induces intracellular acidosis, lipid peroxidation, and peroxynitrite production resulting in the generation of oxidative and nitrosative stress in the ischemic tissue. Here, we studied the effects of acute hyperglycemia on in vivo intercellular adhesion molecule-1 (ICAM-1) expression, neutrophil recruitment, and brain damage after ischemia/reperfusion in mice and tested whether the natural antioxidant uric acid was protective. Hyperglycemia was induced by i.p. administration of dextrose 45 min before transient occlusion of the middle cerebral artery. Magnetic resonance imaging (MRI) was performed at 24 h to measure lesion volume. A group of normoglycemic and hyperglycemic mice received an i.v. injection of micron-sized particles of iron oxide (MPIOs), conjugated with either anti-ICAM-1 antibody or control IgG, followed by T2*w MRI. Neutrophil infiltration was studied by immunofluorescence and flow cytometry. A group of hyperglycemic mice received an i.v. infusion of uric acid (16 mg/kg) or the vehicle starting after 45 min of reperfusion. ICAM-1-targeted MPIOs induced significantly larger MRI contrast-enhancing effects in the ischemic brain of hyperglycemic mice, which also showed more infiltrating neutrophils and larger lesions than normoglycemic mice. Uric acid reduced infarct volume in hyperglycemic mice but it did not prevent vascular ICAM-1 upregulation and did not significantly reduce the number of neutrophils in the ischemic brain tissue. In conclusion, hyperglycemia enhances stroke-induced vascular ICAM-1 and neutrophil infiltration and exacerbates the brain lesion. Uric acid reduces the lesion size after ischemia/reperfusion in hyperglycemic mice., This work was supported by the Spanish Ministerio de Economia y Competitividad (SAF2014-56279R and DPI2015-64358-C2-2-R) and the Netherlands Organization for Scientific Research (NWO; VIDI 917.76.347)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Activation mapping in multi-center retrospective rat sensory-evoked functional MRI datasets using a unified pipeline

  • Galteau, Marie E.
  • Broadwater, Margaret
  • Chen, Yi
  • Desrosiers, Gabriel
  • Gil, Rita
  • Kaesser, Johannes
  • Kim, Eugene
  • Kıryağdı, Pervin
  • Lambers, Henriette
  • Liu, Yanyan Y.
  • López Gil, Xavier
  • MacNicol, Eilidh
  • Mohebkhodaei, Parastoo
  • Oliveira, Ricardo X. N. de
  • Pereira, Carolina A.
  • Reimann, Henning M.
  • Rivera, Alejandro
  • Selingue, Erwan
  • Sirmpilatze, Nikoloz
  • Strobelt, Sandra
  • Sumiyoshi, Akira
  • Tham, Channelle
  • Tudela, Raúl
  • Vrooman, Roël M.
  • Wank, Isabel
  • Zhang, Yongzhi
  • Engelenburg, Wessel A. van
  • Baudewig, Jürgen
  • Boretius, Susann
  • Cash, Diana
  • Chakravarty, M. Mallar
  • Chuang, Kai-Hsiang
  • Ciobanu, Luisa
  • Devenyi, Gabriel A.
  • Faber, Cornelius
  • Hess, Andreas
  • Homberg, Judith R.
  • Jelescu, Ileana O.
  • Justicia, Carles
  • Kawashima, Ryuta
  • Niendorf, Thoralf
  • Scheenen, Tom W. J.
  • Shemesh, Noam
  • Soria, Guadalupe
  • Todd, Nick
  • Wachsmuth, Lydia
  • Yu, Xin
  • Zhang, Baogui B.
  • Shih, Yen-Yu Ian
  • Lee, Sung-Ho
  • Grandjean, Joanes
Functional Magnetic Resonance Imaging (fMRI) in rodents is pivotal for understanding the mechanisms underlying Blood Oxygen Level-Dependent (BOLD) signals and phenotyping animal models of disorders, among other applications. Despite its growing use, comparing rodent fMRI results across different research sites remains challenging due to variations in experimental protocols. Here, we aggregated and analyzed 22 sensory-evoked rat fMRI datasets from 12 imaging centers, totaling scans from 220 rats, to get a snapshot of the current acquisitions in the field. This retrospective analysis highlights common practices and parameters to inform future cross-laboratory standardization efforts. We applied a standardized preprocessing pipeline and evaluated the impact of different hemodynamic response function models on group- and individual-level activity patterns. Our analysis revealed inter-dataset variability attributed to differences in experimental design, anesthesia protocols, and imaging parameters. We identified robust activation clusters in all (22/22) datasets. The comparison between stock human models implemented in software and rat-specific models showed significant variations in the resulting statistical maps. Our findings emphasize the necessity for standardized protocols and collaborative efforts to improve the reproducibility and reliability of rodent fMRI studies. We provide open access to all datasets and analysis code to foster transparency and further research in the field., This project was kindly supported by the Dutch Research Council (OCENW.KLEIN.334, OSF23.1.037), National Institute of Health (K01EB023983, T32 AA007573), Deutsche Forschungsgemeinschaft (406818964), UK Biotechnology and Biological Sciences Research Council (BBSRC, BB/N009088/1), UK Medical Research Council (MR/N013700/1), European Research Council (ERC; agreement No. PI18/00893, 896245, 679058), Ministerio de Economía y Competitividad (DPI2015-64358-C2-2-R), Fonds de recherche du Québec, Interdisciplinary Center for Clinical Research Münster (PIX), and Fundação para a Ciência e Tecnologia (Portugal, project 275-FCT-PTDC/ BBB-IMG/5132/2014)., Peer reviewed